Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Agape ATP Corporation stock logo
ATPC
Agape ATP
$2.98
-17.2%
$2.81
$1.72
$85.50
$2.98M0.086.24 million shs119,522 shs
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
$16.06
-1.5%
$12.37
$5.26
$86.00
$48.09M0.6411,673 shs5,150 shs
Theratechnologies Inc. stock logo
THTX
Theratechnologies
$3.42
+0.9%
$3.35
$2.24
$3.40
$157.21M0.51506,857 shs3.27 million shs
GeneDx Holdings Corp. stock logo
WGS
GeneDx
$52.21
-7.2%
$55.44
$32.21
$170.87
$1.55B1.961.34 million shs1.18 million shs
10 Stocks Set to Soar in 2026 Cover

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Agape ATP Corporation stock logo
ATPC
Agape ATP
-17.22%-38.81%+9.56%+36.07%-96.10%
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
-1.53%-11.07%+21.94%+10.00%-74.75%
Theratechnologies Inc. stock logo
THTX
Theratechnologies
0.00%0.00%0.00%0.00%+29.51%
GeneDx Holdings Corp. stock logo
WGS
GeneDx
-7.22%+0.42%+50.42%-40.74%-27.88%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Agape ATP Corporation stock logo
ATPC
Agape ATP
$2.98
-17.2%
$2.81
$1.72
$85.50
$2.98M0.086.24 million shs119,522 shs
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
$16.06
-1.5%
$12.37
$5.26
$86.00
$48.09M0.6411,673 shs5,150 shs
Theratechnologies Inc. stock logo
THTX
Theratechnologies
$3.42
+0.9%
$3.35
$2.24
$3.40
$157.21M0.51506,857 shs3.27 million shs
GeneDx Holdings Corp. stock logo
WGS
GeneDx
$52.21
-7.2%
$55.44
$32.21
$170.87
$1.55B1.961.34 million shs1.18 million shs
10 Stocks Set to Soar in 2026 Cover

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Agape ATP Corporation stock logo
ATPC
Agape ATP
-17.22%-38.81%+9.56%+36.07%-96.10%
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
-1.53%-11.07%+21.94%+10.00%-74.75%
Theratechnologies Inc. stock logo
THTX
Theratechnologies
0.00%0.00%0.00%0.00%+29.51%
GeneDx Holdings Corp. stock logo
WGS
GeneDx
-7.22%+0.42%+50.42%-40.74%-27.88%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Agape ATP Corporation stock logo
ATPC
Agape ATP
1.00
SellN/AN/A
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
2.00
Hold$55.00242.47% Upside
Theratechnologies Inc. stock logo
THTX
Theratechnologies
1.50
ReduceN/AN/A
GeneDx Holdings Corp. stock logo
WGS
GeneDx
2.63
Moderate Buy$96.4384.69% Upside

Current Analyst Ratings Breakdown

Latest ATPC, EUDA, WGS, and THTX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/1/2026
GeneDx Holdings Corp. stock logo
WGS
GeneDx
DowngradeSell (D-)Sell (E+)
5/22/2026
Agape ATP Corporation stock logo
ATPC
Agape ATP
Reiterated RatingSell (E+)
5/15/2026
GeneDx Holdings Corp. stock logo
WGS
GeneDx
UpgradeSell (E+)Sell (D-)
5/8/2026
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
DowngradeSell (D)Sell (E+)
5/8/2026
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
UpgradeStrong SellHold
5/5/2026
GeneDx Holdings Corp. stock logo
WGS
GeneDx
Reiterated RatingBuy$85.00
5/5/2026
GeneDx Holdings Corp. stock logo
WGS
GeneDx
Set Price TargetBuy$100.00 ➝ $75.00
5/5/2026
GeneDx Holdings Corp. stock logo
WGS
GeneDx
Reiterated RatingOverweight$155.00 ➝ $75.00
5/5/2026
GeneDx Holdings Corp. stock logo
WGS
GeneDx
Lower Price TargetBuy$100.00 ➝ $70.00
5/5/2026
GeneDx Holdings Corp. stock logo
WGS
GeneDx
Lower Price TargetBuy$170.00 ➝ $90.00
4/24/2026
GeneDx Holdings Corp. stock logo
WGS
GeneDx
DowngradeStrong-BuyHold
(Data available from 6/6/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Agape ATP Corporation stock logo
ATPC
Agape ATP
$1.51M1.98N/AN/A$22.41 per share0.13
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
$6.82M7.05N/AN/A($2.26) per share-7.11
Theratechnologies Inc. stock logo
THTX
Theratechnologies
$84.38M1.86N/AN/A($0.55) per share-6.22
GeneDx Holdings Corp. stock logo
WGS
GeneDx
$442.68M3.50$2.13 per share24.55$10.54 per share4.95
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Agape ATP Corporation stock logo
ATPC
Agape ATP
-$2.28M-$1.33N/AN/AN/A-125.89%-8.43%-7.75%N/A
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
-$2.77M-$2.40N/AN/AN/AN/AN/AN/A7/28/2026 (Estimated)
Theratechnologies Inc. stock logo
THTX
Theratechnologies
-$8.31M-$0.19N/A48.84N/A-10.85%N/A-9.83%N/A
GeneDx Holdings Corp. stock logo
WGS
GeneDx
-$21.02M-$2.68N/A60.01N/A-17.58%9.15%5.21%8/4/2026 (Estimated)

Latest ATPC, EUDA, WGS, and THTX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/15/2026Q1 2026
Agape ATP Corporation stock logo
ATPC
Agape ATP
N/A-$0.33N/A-$0.33N/A$0.27 million
5/5/2026Q4 2025
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
-$1.20-$0.44+$0.76-$0.44$3.90 million$1.92 million
5/4/2026Q1 2026
GeneDx Holdings Corp. stock logo
WGS
GeneDx
-$0.06-$0.28-$0.22-$2.16$112.46 million$102.25 million
4/13/2026Q4 2025
Agape ATP Corporation stock logo
ATPC
Agape ATP
N/A-$0.35N/A-$0.35N/A$0.40 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Agape ATP Corporation stock logo
ATPC
Agape ATP
N/AN/AN/AN/AN/A
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
N/AN/AN/AN/AN/A
Theratechnologies Inc. stock logo
THTX
Theratechnologies
N/AN/AN/AN/AN/A
GeneDx Holdings Corp. stock logo
WGS
GeneDx
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Agape ATP Corporation stock logo
ATPC
Agape ATP
N/A
9.01
9.01
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
N/A
0.18
0.18
Theratechnologies Inc. stock logo
THTX
Theratechnologies
N/A
0.84
0.65
GeneDx Holdings Corp. stock logo
WGS
GeneDx
0.38
3.09
2.95

Institutional Ownership

CompanyInstitutional Ownership
Agape ATP Corporation stock logo
ATPC
Agape ATP
0.01%
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
4.35%
Theratechnologies Inc. stock logo
THTX
Theratechnologies
N/A
GeneDx Holdings Corp. stock logo
WGS
GeneDx
61.72%

Insider Ownership

CompanyInsider Ownership
Agape ATP Corporation stock logo
ATPC
Agape ATP
2.04%
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
N/A
Theratechnologies Inc. stock logo
THTX
Theratechnologies
N/A
GeneDx Holdings Corp. stock logo
WGS
GeneDx
29.60%
CompanyEmployeesShares OutstandingFree FloatOptionable
Agape ATP Corporation stock logo
ATPC
Agape ATP
401.00 million981,000Not Optionable
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
22.99 millionN/ANot Optionable
Theratechnologies Inc. stock logo
THTX
Theratechnologies
14045.98 millionN/AOptionable
GeneDx Holdings Corp. stock logo
WGS
GeneDx
1,30029.69 million20.90 millionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Agape ATP stock logo

Agape ATP NASDAQ:ATPC

$2.98 -0.62 (-17.22%)
Closing price 06/5/2026 04:00 PM Eastern
Extended Trading
$3.06 +0.09 (+2.85%)
As of 06/5/2026 07:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Agape ATP Corporation, an investment holding company, supplies health and wellness products and health solution advisory services in Malaysia. It offers four series of programs that consist of various services and products under the ATP Zeta Health Program, ÉNERGÉTIQUE, BEAUNIQUE, and E.A.T.S. names. The company's products include ATP1s Survivor Select that contains various essential nutrients required by the human body to maintain normal metabolism; ATP3 Ionized Cal-Mag, a calcium and magnesium minerals supplement; ATP4 Omega Blend, an oil blend that provides a bio-effective balance of essential fatty acids, omega 3, and omega 6; ATP5 BetaMaxx, a natural immune enhancer; AGN-Vege Fruit Fiber, a nutrition-based formulation for intestines and stomach; AGP1-Iron to improve iron deficiency anemia; and YFA-Young Formula, an anti-aging and youthful maintenance supplement. It also provides BEAUNIQUE brand products comprising Mito+, an antioxidant drink for cellular, immune, metabolic, brain, and skin health; and Trim+, which inhibits the activities of carbohydrates digestive enzymes that result in a reduction of the breakdown and absorption of sugars. In addition, the company offers energy masks, including N°1 Med-Hydration, N°2 Med-Whitening, and N°3 Med-Firming, as well as hyaluronic acid serum and mousse facial cleanser under ÉNERGÉTIQUE brand; and soy protein isolate powder, and an antioxidant under Livo5 brand name. Further, it sells health and wellness products; and promotes wellness and wellbeing lifestyle through online editorials, programs, events, and campaigns, as well as provides health therapies. The company was incorporated in 2016 and is headquartered in Kuala Lumpur, Malaysia.

EUDA Health stock logo

EUDA Health NASDAQ:EUDA

$16.06 -0.25 (-1.53%)
Closing price 06/5/2026 04:00 PM Eastern
Extended Trading
$16.00 -0.06 (-0.37%)
As of 06/5/2026 07:16 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

EUDA Health Holdings Limited operates as a healthcare specialty company. The company operates through two segments, Medical Services and Property Management Services. It offers a range of specialty care services to patients; and operates medical facility general practice clinic that provides holistic care for various illnesses. The company is also involved in the property management that services shopping malls, business office building, or residential apartments. EUDA Health Holdings Limited is headquartered in Singapore.

Theratechnologies stock logo

Theratechnologies NASDAQ:THTX

Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA SV for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo for the treatment of HIV-1 infection in heavily treatment-experienced adults with multidrug-resistant HIV-1 infection failing their current antiretroviral regimen. Its pipeline products include F8 Formulation that is in Phase 2b/3 clinical trials for studying tesamorelin for the treatment of nonalcoholic steatohepatitis; multi -dose pen injector for the administration of tesamorelin; SORT1+ Technology Platform for the development of proprietary peptides for cancer drug development targeting SORT1 receptors; Sudocetaxel Zendusortide, which is in Phase 1 Clinical Trial for various solid tumor types, including HR+ breast, triple negative breast, ovarian, endometrial, melanoma, thyroid, small cell lung, and prostate cancers. The company was incorporated in 1993 and is headquartered in Montreal, Canada.

GeneDx stock logo

GeneDx NASDAQ:WGS

$52.21 -4.06 (-7.22%)
Closing price 06/5/2026 04:00 PM Eastern
Extended Trading
$52.14 -0.07 (-0.13%)
As of 06/5/2026 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. was founded in 2017 and is headquartered in Stamford, Connecticut.